A system for assessing and managing complex brain disorders
Multidisciplinary Expert System for the Assessment & Management of Complex Brain Disorders
This study is testing a new system that uses real-world data and technology to help doctors better diagnose and treat people with complex brain disorders like dementia, epilepsy, and sleep issues.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 350 (estimated) |
| Sex | All |
| Sponsor | Neurological Institute of Athens Academic / other |
| Locations | 4 sites (Athens and 3 other locations) |
| Trial ID | NCT05171725 on ClinicalTrials.gov |
What this trial studies
The Multidisciplinary Expert System for the Assessment & Management of Complex Brain Disorders (MES-CoBraD) is an interdisciplinary initiative that integrates Real-World Data from various clinical and consumer sources to enhance diagnostic accuracy and therapeutic outcomes for individuals with complex brain disorders such as dementia, epilepsy, and sleep disorders. This project involves collaboration among experts in medicine, engineering, computer science, and social health sciences across Europe, utilizing advanced technologies like artificial intelligence and secure data-sharing platforms. The goal is to provide precision and personalized care, ultimately improving the quality of life for patients and their caregivers.
Who should consider this trial
Good fit: Ideal candidates include individuals experiencing complex brain disorders such as dementia, epilepsy, or sleep disorders, as well as healthy volunteers willing to participate in comprehensive assessments.
Not a fit: Patients who are not interested in undergoing comprehensive assessments or those who do not meet the inclusion criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the diagnosis and management of complex brain disorders, leading to better patient outcomes.
How similar studies have performed: Other studies utilizing multidisciplinary approaches and artificial intelligence in managing complex brain disorders have shown promise, indicating potential for success in this novel initiative.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All participants willing to undergo comprehensive assessment who visit one of three clinics (Epilepsy, Neurocognitive disorders, and Sleep Disorders), and healthy volunteers Exclusion Criteria: * participant disinterest
Where this trial is running
Athens and 3 other locations
- Neurological Institute of Athens — Athens, Greece (Recruiting)
- Rabin Medical Center — Petah Tikva, Israel (Recruiting)
- Sant Pau Memory Clinic — Barcelona, Spain (Recruiting)
- King's College London — London, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Athena Tsakopoulou
- Email: a.tsakopoulou@nioa.gr
- Phone: +302107217457
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.